首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.
【2h】

Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.

机译:用促黄体激素释放激素的激动剂和拮抗剂治疗后邓宁R3327前列腺癌的AgNOR值降低。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The argyrophilic staining of the nucleolar organizer region (AgNOR) in cells of Dunning R3327 rat prostate tumors was studied and the effect of hormonal treatments on their appearance was analyzed. The nuclei of the control tumor cells contained 4.1 +/- 0.17 AgNOR granules. Treatment of rats for 8 weeks with luteinizing hormone-releasing hormone (LH-RH) agonist (D-Trp-6-LH-RH) and antagonist SB-75 induced a marked inhibition of tumor growth and decreased significantly (P less than 0.01) the number of Ag-NORs in the tumors to 2.89 +/- 0.10 AgNOR granules/cell in the group given the agonist and to 2.82 +/- 0.10 after therapy with the highest dose of the antagonist. A reduced AgNOR number (3.14 +/- 0.16) also was found after 3 days of treatment with SB-75 (P less than 0.05), but the AgNORs returned to near control values 1 week after the short-term therapy, showing the reversibility of these changes. These results suggest that the AgNOR method, which was widely tested on human tumors in the past few years, can be a valuable technique in experimental tumor pathology and useful in the evaluation of the effects of various treatments.
机译:研究了Dunning R3327大鼠前列腺肿瘤细胞中核仁组织区(AgNOR)的嗜银染色,并分析了激素治疗对其外观的影响。对照肿瘤细胞的细胞核含有4.1 +/- 0.17AgNOR颗粒。用促黄体激素释放激素(LH-RH)激动剂(D-Trp-6-LH-RH)和拮抗剂SB-75治疗大鼠8周,可显着抑制肿瘤生长并显着降低(P小于0.01)给予激动剂的组中肿瘤中Ag-NOR的数量为2.89 +/- 0.10 AgNOR颗粒/细胞,用最高剂量的拮抗剂治疗后为2.82 +/- 0.10。用SB-75治疗3天后,发现AgNOR值降低(3.14 +/- 0.16)(P小于0.05),但短期治疗后1周,AgNORs恢复到接近控制值,显示出可逆性这些变化。这些结果表明,在过去的几年中已在人类肿瘤上进行了广泛测试的AgNOR方法在实验性肿瘤病理学中可能是一种有价值的技术,并且可用于评估各种治疗的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号